Home » Newsletters » BioWorld Science

BioWorld Science

April 27, 2021

View Archived Issues

Alethia studies AB-16B5 with docetaxel in phase II for metastatic NSCLC

Beth Israel Deaconess Medical Center presents anti-Tn antibodies

Janssen R&D Ireland divulges new antituberculous compounds

ER-alpha antagonists and SERDs patented by Sanofi

Bayer discovers BCAT1/2 ihibitors

HBV HBeAg and HBsAg secretion inhibitors identified at Roche

Acylaminooxadiazoles inhibit trans-translation and show in vivo efficacy against N. gonorrhoeae

A new knock-in mouse model related to spinocerebellar ataxia 14

Harpoon Therapeutics develops FLT3-targeting TriTACs for treating acute myeloid leukemia

CD161 linked to outcomes in head and neck cancer patients

NX-1607 targets E3 ubiquitin-protein ligase CBL-B for antitumor immunotherapy

Aurigene details preclinical activity of anticancer compounds AU-18069 and AU-19820

Soticlestat reduces frequency of seizures in pediatric patients with DS and LGS

Autophagy chaperone targets aggregation-prone proteins

FDA removes clinical hold on IND application for VY-HTT01

Promising phase II data presented for olamkicept in ulcerative colitis

First patient enrolled in phase IIa study of CM-101 in NASH

Roflumilast demonstrates cognition-enhancing effects in patients with schizophrenia

Reviva reports strong phase II data in schizophrenia

Neoleukin to proceed with phase I study of NL-201 in the U.S.

FDA removes clinical hold on uniQure's hemophilia B gene therapy program

Cybin targets IND filing for CYB-003 for alcohol use disorder by year-end

CoA Therapeutics initiates phase I study of BBP-671

FYB-207 advancing towards clinical trials for COVID-19 in fourth quarter

SciClone evaluates COVID-19 inactivated vaccine with Zadaxin in China

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...